Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Phase II results with Immunex's Flt3 ligand reported

June 27, 1997

Kyowa Hakko discloses new calcitonin derivatives

June 27, 1997

Hypolipidemic effects of F-1394 in hyperlipidemic dogs

June 26, 1997

Potential new antidiabetic and antiobesity agent from Dainippon

June 26, 1997

Positive efficacy profile for MacroChem's erectile dysfunction therapy

June 26, 1997

Encouraging data reported for Sugen's insulin phosphatase inhibitors

June 26, 1997

Kyowa Hakko claims compounds for thrombocytopenia

June 26, 1997

Amylin and J&J expand product development program

June 25, 1997

Update on clinical progression of Amylin's diabetes drug

June 25, 1997

DuPont Merck seeks to license cholesterol-lowering agent

June 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...